Your browser is no longer supported. Please, upgrade your browser.
HOOK HOOKIPA Pharma Inc. monthly Stock Chart
HOOK [NASD]
HOOKIPA Pharma Inc.
Index- P/E- EPS (ttm)-1.55 Insider Own0.30% Shs Outstand25.65M Perf Week-12.86%
Market Cap251.07M Forward P/E- EPS next Y-1.96 Insider Trans-43.82% Shs Float18.60M Perf Month5.21%
Income-39.60M PEG- EPS next Q-0.45 Inst Own64.20% Short Float4.47% Perf Quarter-14.63%
Sales16.00M P/S15.69 EPS this Y-277.10% Inst Trans4.12% Short Ratio12.03 Perf Half Y10.36%
Book/sh4.05 P/B2.39 EPS next Y-18.10% ROA-28.10% Target Price19.00 Perf Year23.13%
Cash/sh3.59 P/C2.70 EPS next 5Y4.80% ROE-34.70% 52W Range5.80 - 14.37 Perf YTD-20.77%
Dividend- P/FCF- EPS past 5Y- ROI-41.50% 52W High-32.55% Beta-
Dividend %- Quick Ratio6.30 Sales past 5Y- Gross Margin- 52W Low67.07% ATR0.82
Employees85 Current Ratio6.30 Sales Q/Q63.40% Oper. Margin- RSI (14)47.22 Volatility6.59% 8.55%
OptionableYes Debt/Eq0.04 EPS Q/Q56.00% Profit Margin- Rel Volume0.57 Prev Close9.55
ShortableYes LT Debt/Eq0.04 EarningsAug 13 BMO Payout- Avg Volume69.13K Price9.69
Recom1.40 SMA20-0.51% SMA50-5.00% SMA200-5.63% Volume39,563 Change1.47%
Sep-27-19Initiated H.C. Wainwright Buy $15
May-13-19Initiated RBC Capital Mkts Outperform $23
May-13-19Initiated BofA/Merrill Buy $17
Sep-16-20 07:45AM  
07:00AM  
Sep-09-20 07:30AM  
Aug-13-20 10:35AM  
07:20AM  
07:00AM  
Aug-06-20 12:30PM  
Aug-04-20 07:00AM  
Aug-03-20 12:31PM  
07:00AM  
Jul-23-20 03:24PM  
Jun-22-20 07:15AM  
Jun-19-20 07:00AM  
Jun-17-20 07:00AM  
Jun-12-20 02:04PM  
Jun-11-20 08:34AM  
May-26-20 07:30AM  
May-17-20 09:31AM  
May-14-20 08:15AM  
07:00AM  
May-07-20 12:30PM  
May-04-20 07:00AM  
Apr-29-20 07:00AM  
Apr-21-20 07:00AM  
Apr-19-20 10:33AM  
Mar-19-20 07:00AM  
06:00AM  
Mar-10-20 08:15AM  
Feb-18-20 08:00AM  
Jan-15-20 09:53AM  
Jan-06-20 07:00AM  
Dec-30-19 07:30AM  
Dec-20-19 02:27PM  
Nov-25-19 08:00AM  
Nov-12-19 04:01PM  
Nov-04-19 08:00AM  
Oct-31-19 08:15AM  
Sep-25-19 08:30AM  
Sep-19-19 08:55AM  
Aug-29-19 08:30AM  
Aug-12-19 04:01PM  
Jul-19-19 01:37PM  
Jul-17-19 10:06AM  
Jul-12-19 07:58AM  
07:24AM  
Jul-11-19 04:37PM  
04:01PM  
02:05PM  
Jun-10-19 09:10AM  
May-20-19 04:01PM  
May-08-19 03:47AM  
Apr-25-19 08:30AM  
Apr-18-19 11:01AM  
07:26AM  
Apr-17-19 10:49PM  
Apr-14-19 09:53AM  
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immune-therapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop infectious disease product candidates intended to support functional cures for chronic Hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SOFINNOVA CAPITAL VI FCPR10% OwnerSep 15Sale12.6141,597524,4773,906,494Sep 17 04:02 PM
SOFINNOVA CAPITAL VI FCPR10% OwnerJul 20Sale11.9412,483149,1023,948,091Jul 22 04:03 PM
SOFINNOVA CAPITAL VI FCPR10% OwnerJun 29Sale11.783,28038,6283,960,574Jul 22 04:03 PM
SOFINNOVA CAPITAL VI FCPR10% OwnerJun 29Sale11.783,28038,6283,960,574Jul 01 04:16 PM
Matushansky IgorChief Medical OfficerJan 29Sale12.735,50069,99253,398Jan 31 04:01 PM
Lilja AndersSr. VP, Technical DevelopmentJan 23Option Exercise0.1011,6431,1647,568Jan 27 04:52 PM
Lilja AndersSr. VP, Technical DevelopmentJan 23Sale12.5911,643146,5330Jan 27 04:52 PM
Orlinger KlausSr. VP, ResearchJan 21Option Exercise0.106,7896796,789Jan 21 04:44 PM
Orlinger KlausSr. VP, ResearchJan 21Sale12.026,78981,5920Jan 21 04:44 PM
Orlinger KlausSr. VP, ResearchJan 16Option Exercise0.101,7111711,711Jan 21 04:44 PM
Orlinger KlausSr. VP, ResearchJan 16Sale11.561,71119,7810Jan 21 04:44 PM
Orlinger KlausSr. VP, ResearchJan 14Option Exercise0.108,5008508,500Jan 16 04:06 PM
Orlinger KlausSr. VP, ResearchJan 14Sale11.308,50096,0530Jan 16 04:06 PM
Matushansky IgorChief Medical OfficerDec 19Option Exercise0.1025,8912,58969,302Dec 23 08:30 AM
Matushansky IgorChief Medical OfficerDec 19Sale9.9310,404103,31258,898Dec 23 08:30 AM
Matushansky IgorChief Medical OfficerDec 17Option Exercise0.1026,3122,63154,895Dec 19 04:03 PM
Matushansky IgorChief Medical OfficerDec 17Sale7.8711,48490,37943,411Dec 19 04:03 PM